SRR1441546
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1474333 | GTEX | — | 0.944 |
| 2 | SRR1354734 | GTEX | — | 0.944 |
| 3 | SRR1316297 | GTEX | — | 0.938 |
| 4 | SRR1336158 | GTEX | — | 0.938 |
| 5 | SRR1405007 | GTEX | — | 0.937 |
| 6 | SRR1433431 | GTEX | — | 0.931 |
| 7 | SRR1391922 | GTEX | — | 0.929 |
| 8 | SRR1332796 | GTEX | — | 0.928 |
| 9 | SRR1320963 | GTEX | — | 0.926 |
| 10 | SRR1487321 | GTEX | — | 0.922 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 19 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| PANCREAS_BETA_CELLS | 0.410 | Cobimetinib | — uncovered |
| KRAS_SIGNALING_DN | 0.400 | Remibrutinib | — uncovered |
| MYOGENESIS | 0.360 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.266 | Remibrutinib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.253 | Inavolisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.238 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.200 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.169 | Idelalisib | — uncovered |
| BILE_ACID_METABOLISM | 0.155 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.147 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.140 | Inavolisib | — uncovered |
| COAGULATION | 0.134 | Binimetinib | — uncovered |
| APICAL_SURFACE | 0.111 | Temsirolimus | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.099 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.061 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.058 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.033 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.017 | Remibrutinib | — uncovered |
| NOTCH_SIGNALING | 0.012 | Inavolisib | — uncovered |